pembrolizumab,toripalimab,nivolumab,ipilimumab,Atezolizumab,durvalumab,Cisplatin,Vinorelbine,Gemcitabine,Docetaxel,Pemetrexed,Carboplatin,Paclitaxel
merck,Roche,BMS,Coherus,Junshi Biosciences,Astrazeneca
['kn-671', 'lcsm,(-blcsm)']
very nice discussion by putting kn-671 into context &amp; asking important qs about clinical implications in an increasingly crowded setting. #asco23 #lcsm #oncoalert 
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website